Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05590273 · ClinicalTrials.gov registry record · NA
Forgotten Voices: Addressing Unmet Needs in Brain Tumor Caregivers
A NA study, sponsored by Virginia Commonwealth University.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT05590273 is a NA study that was terminated before completion, run by Virginia Commonwealth University. The registered enrollment target is 1 participants.
The verdict
NCT05590273, a NA study, was terminated before completion, sponsored by Virginia Commonwealth University.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
To conduct a mixed-method Phase Ia Define Trial of caregivers' participation in CALM therapy with post-session surveys and individual exit interviews in order to evaluate suitability and adapt the CALM intervention to the needs of caregivers in neuro-oncology.
Interventions
- BEHAVIORAL CALM Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2022-11-03 |
| Est. Completion | 2023-03-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05590273
The ClinicalTrials.gov registry entry for NCT05590273 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CALM Therapy is the first listed.
NCT05590273 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05590273 about?
NCT05590273 is a clinical study titled "Forgotten Voices: Addressing Unmet Needs in Brain Tumor Caregivers". To conduct a mixed-method Phase Ia Define Trial of caregivers' participation in CALM therapy with post-session surveys and individual exit interviews in order to evaluate suitability and adapt the CALM intervention to the needs of caregivers in neuro-oncology.
What is the current status of trial NCT05590273?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2022-11-03. Estimated completion is 2023-03-28.
What interventions are being tested in trial NCT05590273?
The interventions under investigation include: CALM Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT05590273?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.